TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pfizer Health AB
Closing information (x1000 EUR)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
383,053
|
553,067
|
387,861 |
| Financial expenses |
260
|
0
|
92 |
| Earnings before taxes |
179,198
|
344,945
|
246,463 |
| EBITDA |
184,581
|
345,558
|
257,628 |
| Total assets |
699,253
|
964,237
|
883,166 |
| Current assets |
482,549
|
749,816
|
661,871 |
| Current liabilities |
100,017
|
106,467
|
73,490 |
| Equity capital |
577,637
|
839,812
|
790,614 |
| - share capital |
222,087
|
223,781
|
234,108 |
| Employees (average) |
337
|
340
|
325 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
82.6%
|
87.1%
|
89.5% |
| Turnover per employee |
1,137
|
1,627
|
1,193 |
| Profit as a percentage of turnover |
46.8%
|
62.4%
|
63.5% |
| Return on assets (ROA) |
25.7%
|
35.8%
|
27.9% |
| Current ratio |
482.5%
|
704.3%
|
900.6% |
| Return on equity (ROE) |
31.0%
|
41.1%
|
31.2% |
| Change turnover |
-165,827
|
182,314
|
92,069 |
| Change turnover % |
-30%
|
49%
|
31% |
| Chg. No. of employees |
-3
|
15
|
14 |
| Chg. No. of employees % |
-1%
|
5%
|
5% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.